BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36000989)

  • 1. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
    Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
    Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
    Quinn KP; Tabibian JH; Lindor KD
    Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
    Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
    Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
    Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
    Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
    Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
    Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients.
    Ainthachot S; Sa-Ngiamwibool P; Thanee M; Watcharadetwittaya S; Chamgramol Y; Pairojkul C; Deenonpoe R
    Hum Pathol; 2022 Aug; 126():31-44. PubMed ID: 35577140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.
    Bangarulingam SY; Bjornsson E; Enders F; Barr Fritcher EG; Gores G; Halling KC; Lindor KD
    Hepatology; 2010 Jan; 51(1):174-80. PubMed ID: 19877179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.
    Scheid JF; Rosenbaum MW; Przybyszewski EM; Krishnan K; Forcione DG; Iafrate AJ; Staller KD; Misdraji J; Lennerz JK; Pitman MB; Pratt DS
    Cancer Cytopathol; 2022 Mar; 130(3):215-230. PubMed ID: 34726838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas.
    DeHaan RD; Kipp BR; Smyrk TC; Abraham SC; Roberts LR; Halling KC
    Hum Pathol; 2007 Mar; 38(3):491-9. PubMed ID: 17239935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.
    Navaneethan U; Njei B; Venkatesh PG; Vargo JJ; Parsi MA
    Gastrointest Endosc; 2014 Jun; 79(6):943-950.e3. PubMed ID: 24360654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Njei B; McCarty TR; Varadarajulu S; Navaneethan U
    Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recall processes for biliary cytology in primary sclerosing cholangitis.
    Eaton JE; Gossard AA; Talwalkar JA
    Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
    Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
    Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
    Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.